{"entity":{"type":"insider","cik":"0001959750","url":"/insider/0001959750","json_url":"/insider/0001959750.json","name":"Arif Bilal","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":2,"first":"2024-03-05","last":"2024-06-25","span_basis":"filed_date"},"name_variants":[{"name":"Arif Bilal","source":"filing","n_filings":2,"first_seen":"2024-03-05","last_seen":"2024-06-25"}],"transactions":[{"id":2205714,"accession":"0000950170-24-077518","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950170-24-077518","line_url":"/filing/0000950170-24-077518#line-8","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001959750","owner_name":"Arif Bilal","owner_url":"/insider/0001959750","role":"Officer (Chief Tech Ops Officer)","officer_title":"Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3898.0,"shares_display":"3,898","price_per_share":163.23,"price_display":"163.23","price_state":"stated","total_value":636270.54,"total_display":"636,270.54","shares_owned_after":17363.0,"shares_owned_after_display":"17,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-25","scope":"insider"},{"id":2205712,"accession":"0000950170-24-077518","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950170-24-077518","line_url":"/filing/0000950170-24-077518#line-7","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001959750","owner_name":"Arif Bilal","owner_url":"/insider/0001959750","role":"Officer (Chief Tech Ops Officer)","officer_title":"Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5580.0,"shares_display":"5,580","price_per_share":162.31,"price_display":"162.31","price_state":"stated","total_value":905689.8,"total_display":"905,689.80","shares_owned_after":23540.0,"shares_owned_after_display":"23,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-24","filed_date":"2024-06-25","scope":"insider"},{"id":2205710,"accession":"0000950170-24-077518","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-24-077518","line_url":"/filing/0000950170-24-077518#line-6","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001959750","owner_name":"Arif Bilal","owner_url":"/insider/0001959750","role":"Officer (Chief Tech Ops Officer)","officer_title":"Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1055.0,"shares_display":"1,055","price_per_share":163.83,"price_display":"163.83","price_state":"stated","total_value":172840.65,"total_display":"172,840.65","shares_owned_after":22485.0,"shares_owned_after_display":"22,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-24","filed_date":"2024-06-25","scope":"insider"},{"id":2205708,"accession":"0000950170-24-077518","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-077518","line_url":"/filing/0000950170-24-077518#line-5","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001959750","owner_name":"Arif Bilal","owner_url":"/insider/0001959750","role":"Officer (Chief Tech Ops Officer)","officer_title":"Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":166.1,"price_display":"166.10","price_state":"stated","total_value":116270.0,"total_display":"116,270.00","shares_owned_after":21485.0,"shares_owned_after_display":"21,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-24","filed_date":"2024-06-25","scope":"insider"},{"id":2205706,"accession":"0000950170-24-077518","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-077518","line_url":"/filing/0000950170-24-077518#line-4","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001959750","owner_name":"Arif Bilal","owner_url":"/insider/0001959750","role":"Officer (Chief Tech Ops Officer)","officer_title":"Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":164.61,"price_display":"164.61","price_state":"stated","total_value":49383.0,"total_display":"49,383.00","shares_owned_after":22185.0,"shares_owned_after_display":"22,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-24","filed_date":"2024-06-25","scope":"insider"},{"id":2205703,"accession":"0000950170-24-077518","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-077518","line_url":"/filing/0000950170-24-077518#line-3","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001959750","owner_name":"Arif Bilal","owner_url":"/insider/0001959750","role":"Officer (Chief Tech Ops Officer)","officer_title":"Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":224.0,"shares_display":"224","price_per_share":167.13,"price_display":"167.13","price_state":"stated","total_value":37437.12,"total_display":"37,437.12","shares_owned_after":21261.0,"shares_owned_after_display":"21,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-24","filed_date":"2024-06-25","scope":"insider"},{"id":2849661,"accession":"0000950170-24-026606","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-026606","line_url":"/filing/0000950170-24-026606#line-5","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001959750","owner_name":"Arif Bilal","owner_url":"/insider/0001959750","role":"Officer (Chief Tech Ops Officer)","officer_title":"Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1543.0,"shares_display":"1,543","price_per_share":128.58,"price_display":"128.58","price_state":"stated","total_value":198398.94,"total_display":"198,398.94","shares_owned_after":27293.0,"shares_owned_after_display":"27,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":2849659,"accession":"0000950170-24-026606","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-026606","line_url":"/filing/0000950170-24-026606#line-4","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001959750","owner_name":"Arif Bilal","owner_url":"/insider/0001959750","role":"Officer (Chief Tech Ops Officer)","officer_title":"Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":457.0,"shares_display":"457","price_per_share":129.71,"price_display":"129.71","price_state":"stated","total_value":59277.47,"total_display":"59,277.47","shares_owned_after":26836.0,"shares_owned_after_display":"26,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000873303","name":"Sarepta Therapeutics, Inc.","url":"/issuer/0000873303","role":"Officer (Chief Tech Ops Officer)","n_filings":2,"first_seen":"2024-03-05","last_seen":"2024-06-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001959750","retrieved_at":"2026-08-21T05:26:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}